|1.||Dietrich, C F: 1 article (12/2011)|
|2.||Strobel, D: 1 article (12/2011)|
|3.||Bernatik, T: 1 article (12/2011)|
|4.||Schuler, A: 1 article (12/2011)|
|5.||Seitz, K: 1 article (12/2011)|
|6.||Blank, W: 1 article (12/2011)|
|7.||Greis, C: 1 article (12/2011)|
04/01/1995 - "During zero flow ischemia, [Na+]i in the control group rose to 15.5 +/- 1.4 mM (P < 0.05) at 6 min, whereas [Na+]i in the group treated with SFLL increased rapidly from the preischemic value of 11.7 +/- 0.3 to 23.5 +/- 1.9 mM (P < 0.01 compared with that in the control group) over the same time period. "
04/01/1995 - "In the present study, the influence of the thrombin receptor activating peptide, SFLLRNPNDKYEPF (SFLL), on intracellular Na+ ([Na+]i) and tissue lysophosphatidylcholine (LPC) content during ischemia was investigated in an isolated, blood-perfused rabbit papillary muscle preparation. "
02/01/1995 - "Subsequently, tumor cells derived from three species, i.e., human, rat, and mouse, were found to express the thrombin receptor protein as revealed by immunoblotting using ligand peptide-derived mAb ATAP138, whose reactivity towards the M(r) approximately 66,000, potential thrombin receptor was blocked by preincubating the antibody with the immunogen peptide SFLLRNPNDKYEPF (TRP 14). "
|3.||Neoplasm Metastasis (Metastasis)
|1.||thrombin receptor peptide (42-55)
|3.||thrombin receptor peptide SFLLRNP
|4.||Thrombin Receptors (Thrombin Receptor)